Synopsis: L&T Technology Services has launched an AI-powered lung digital twin platform built on NVIDIA’s AI infrastructure to help doctors visualize lung anatomy in 3D, improve surgical planning and enhance respiratory diagnostics.

 

New Delhi: L&T Technology Services (LTTS) on Monday announced the launch of an artificial intelligence-powered lung digital twin platform developed using technology from NVIDIA, aimed at improving respiratory diagnostics and surgical planning.

LTTS launches NVIDIA-powered AI lung digital twin platform for respiratory diagnostics
Source: Internet

The next-generation platform enables clinicians to create a 3D digital twin of a patient’s lungs from CT scan data, allowing doctors to visualise complex lung structures and simulate procedures before performing them.

According to the company, the platform integrates with CT imaging workflows and uses deep learning algorithms to reconstruct a detailed digital model of lung anatomy, including airways, blood vessels, lung lobes and lesions.

The solution allows clinicians to explore patient-specific lung anatomy in an immersive environment and simulate navigation pathways for bronchoscopy and biopsy procedures, helping improve precision in surgical planning.

The platform leverages NVIDIA’s AI stack, including Omniverse and OpenUSD for interactive 3D visualization, TensorRT for optimized AI inference in clinical workflows, and MONAI for automated medical image segmentation to identify airways, vessels and tumors.

“By combining LTTS’ engineering expertise in medical imaging and digital health platforms with the power of NVIDIA’s Physical AI infrastructure, we are enabling a new generation of AI-powered biological digital twins for precision medicine,” said Amit Chadha, CEO and Managing Director of LTTS.

David Niewolny, head of business development for healthcare and medical technology at NVIDIA, said digital twins are emerging as a powerful tool in precision medicine, allowing clinicians to simulate procedures and plan interventions with greater confidence.

The company said the technology can transform static CT scans into simulation-ready lung models, enabling doctors to analyse anatomical relationships, plan surgical pathways and navigate bronchoscopic procedures with greater accuracy.

With respiratory diseases such as lung cancer and chronic obstructive pulmonary disease (COPD) rising globally, LTTS said AI-powered digital twin technologies could accelerate the shift toward predictive and simulation-driven healthcare and enable more personalised treatment pathways.

Headquartered in India, LTTS is a listed subsidiary of Larsen & Toubro and provides engineering and technology services across sectors including medical devices, transportation, telecom and industrial products.

Oh hi there 👋 It’s nice to meet you.

Get industry updates ! Subscribe to our Daily Newsletter.

We don’t spam!

Leave a comment

Your email address will not be published. Required fields are marked *